Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance

ADMA Biologics IncTrade
Vanguard International High Dividend Yield ETFTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Vanguard International High Dividend Yield ETF — how do they compare? ADMA Biologics Inc trades at $9.86 (market cap $2.22B), while Vanguard International High Dividend Yield ETF trades at $104.61. The key difference: Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAVYMI
Market Cap
$2.22B
Sector
HealthBroad Market / Factor
52-Week High
$20.38$105.05
52-Week Low
$7.60$82.92
Enterprise Value
$2.29B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Vanguard International High Dividend Yield ETF

VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.

Read more on VYMI